A drug administered to a patient for treatment, listed in SEER*Rx as a chemotherapeutic, hormonal or immunotherapy agent should be coded under chemotherapy [#1390], hormone therapy [#1400] or immunotherapy [#1410] regardless of the primary site(s) listed in SEER*Rx for that agent. Do not code under the data item, Other Therapy [NAACCR #1420]. Refer to the 2026 SEER manual for more information.

Search Database
Name Category Primary Site Code?
Etretinate Differentiation inducing agent No
Methylphenidate Hydrochloride Ancillary Agent No
Midazolam Hydrochloride Ancillary Agent No
Etoprine Ancillary Agent No
U-85961 AIDS drug No
Epoetin Alfa AIDS drug, Ancillary Agent No
Ethacrynic Acid Ancillary Agent No
Trimethobenzamide Hydrochloride Ancillary Agent No
Mirostepin Ancillary Agent Breast cancer No
Etidronate Disodium Ancillary Agent No
Endorphin Ancillary Agent No
Metoclopramide Ancillary Agent No
EMLA Cream (lidocaine 2.5% and prilocaine 2.5%) Ancillary Agent No
Triflupromazine Hydrochloride Ancillary Agent No
U-87201E AIDS drug No
Ethambutol Hydrochloride AIDS drug No
Trichosanthin AIDS drug No
Trimethoprim Ancillary Agent, AIDS drug AIDS, Opportunistic infection No
Tropisetron Ancillary Agent No
Plerixafor Ancillary Agent MM, Multiple myeloma, NHL, Non-hodgkins Lymphoma No
Ethionamide AIDS drug No
Misonidazole Ancillary Agent No
U-90152 AIDS drug No
Trospectomycin Sulfate AIDS drug No
Erythropoietin Ancillary Agent AIDS, Opportunistic infection No
Name Primary Site
VC
VBMF
VBAP
VBA
VB
VAV
VATH
VATD
VAP-II
VAM
VAI
VAFAC
VAD/V
VAD
VACAD
VACA
VABCD
VAB-V
VAB 3
VAB 2
VAB 1
VAAP
UFT
Temozolomide + CRA
Tam Letrozole
Glossary